Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Pfizer Inc
Recent news which mentions Pfizer Inc
< Previous
1
2
...
23
24
25
26
27
28
29
30
Next >
Third juror dismissed in trial of Theranos founder Elizabeth Holmes after judge finds 'good cause' for leave
October 22, 2021
Tags
Health & Science
Trials
Wealth
From
CNBC.com News
U.S. surgeon general offers guidance on how to decide whether to mix-and-match Covid boosters
October 22, 2021
Tags
Vaccinations
Politics
Pfizer Inc
From
CNBC.com News
What to watch today: Stock futures mixed after S&P 500's record close
October 22, 2021
Tags
Mattel Inc
China Evergrande Group
Honeywell International Inc
From
CNBC.com News
5 things to know before the stock market opens Friday
October 22, 2021
Tags
Markets
Interest Rates
Intel Corp
From
CNBC.com News
FDA clears Johnson & Johnson and Moderna booster shots for millions of people
October 20, 2021
Tags
Disease outbreaks
Business
Pfizer Inc
From
CNBC.com News
How rising UK Covid cases could be ‘a compelling argument for boosters’
October 19, 2021
Tags
Science
Pharmaceuticals
Moderna Inc
From
CNBC.com News
What to watch today: Stock futures jump after S&P 500, Nasdaq log 4-day win streaks
October 19, 2021
Tags
Sinclair Broadcast Group Inc
Zions Bancorporation NA
Pfizer Inc
From
CNBC.com News
Stocks making the biggest moves in the premarket: Procter & Gamble, Johnson & Johnson, Travelers and more
October 19, 2021
Tags
Wall Street
Bank of New York Mellon Corp
Moderna Inc
From
CNBC.com News
Reddit channel posts stories of anti-vaxxers dying of Covid, scaring fence-sitters into getting the shot
October 16, 2021
Tags
Johnson & Johnson
US: News
Social media
From
CNBC.com News
Risk of mRNA Covid booster causing heart inflammation in young adults continues to worry scientists, Dr. Ofer Levy says
October 15, 2021
Tags
Business
Politics
Epidemics
From
CNBC.com News
FDA panel unanimously recommends J&J Covid booster shots to millions of Americans
October 15, 2021
Tags
Politics
Pfizer Inc
Epidemics
From
CNBC.com News
What to watch today: Wall Street on track for a winning week on strong earnings
October 15, 2021
Tags
Pearson PLC
Johnson & Johnson
Fubotv Inc
From
CNBC.com News
5 things to know before the stock market opens Friday
October 15, 2021
Tags
Health care industry
Moderna Inc
Economy
From
CNBC.com News
FDA panel unanimously recommends Moderna Covid booster shots for at risk adults
October 14, 2021
Tags
Pandemics
Moderna Inc
Health care industry
From
CNBC.com News
More Americans are getting Covid vaccine boosters than first doses in rush for third shots
October 14, 2021
Tickers
LIFE
Tags
Biotech and Pharmaceuticals
Coronavirus: Reopening the economy
BioNTech SE
From
CNBC.com News
Watch live: FDA advisory panel to vote on Moderna Covid booster shots
October 14, 2021
Tags
U/S/ Economy
Biotech and Pharmaceuticals
Breaking News: Business
From
CNBC.com News
What to watch today: Stock futures rise after S&P 500, Nasdaq broke 3-day losing streaks
October 14, 2021
Tags
Walgreens Boots Alliance Inc
Moderna Inc
Oracle Corp
From
CNBC.com News
5 things to know before the stock market opens Thursday
October 14, 2021
Tags
5 Things to Know
Business News
Walgreens Boots Alliance Inc
From
CNBC.com News
People in Israel and Bahrain are losing their vaccination status for not taking boosters
October 13, 2021
Tags
Immunizations
Pharmaceuticals
Health care industry
From
CNBC.com News
J&J Covid vaccine recipients are better off getting Pfizer or Moderna booster, NIH study suggests
October 13, 2021
Tags
Disease outbreaks
Politics
Epidemics
From
CNBC.com News
White House calls on pediatricians in kids' Covid vaccine rollout starting as early as next month
October 13, 2021
Tags
Coronavirus
US: News
World News
From
CNBC.com News
FDA scientists strike favorable tone on J&J Covid booster shots ahead of vote this week
October 13, 2021
Tags
Policy
Business News
Health care industry
From
CNBC.com News
FDA staff doesn't take stance on Moderna Covid booster shots, says two doses are enough to protect against severe disease
October 12, 2021
Tags
Pandemics
Moderna Inc
Health care industry
From
CNBC.com News
Dr. Scott Gottlieb says Merck's Covid pill ‘can make a real difference’
October 11, 2021
Tags
Personnel
Markets
Merck & Co Inc
From
CNBC.com News
U.S. moves closer to clearing Moderna and J&J Covid booster shots this week
October 11, 2021
Tags
Health & Science
US: News
Coronavirus
From
CNBC.com News
Merck asks FDA to authorize antiviral Covid pill for emergency use
October 11, 2021
Tags
Disease outbreaks
Epidemics
Pfizer Inc
From
CNBC.com News
Nordic countries are restricting the use of Moderna's Covid vaccine. Here's why
October 08, 2021
Tags
Biotech and Pharmaceuticals
Europe News
Health & Science
From
CNBC.com News
‘A historic moment’: Why a malaria vaccine in Africa will reignite the fight against disease
October 08, 2021
Tags
Biotech and Pharmaceuticals
BioNTech SE
Pfizer Inc
From
CNBC.com News
Covid-19: Kids ages 5 to 11 ‘need to get that vaccination,’ says Dr. Peter Hotez
October 07, 2021
Tags
BioNTech SE
Biotech and Pharmaceuticals
World Markets
From
CNBC.com News
Dr. Gottlieb sees Covid’s ‘pandemic phase’ ending when antiviral pills, kids' vaccines available
October 06, 2021
Tags
Immunizations
Coronavirus: Prevention and treatment
Health care industry
From
CNBC.com News
< Previous
1
2
...
23
24
25
26
27
28
29
30
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.